Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| UTI Nifty Midcap 150 Exchange Traded Fund | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | UTI | Nippon India |
| NAV | ₹230.3012 | ₹235.6824 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 3.2 years | 7.8 years |
| Expense ratio | 0.0% | 0.3% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| UTI Nifty Midcap 150 Exchange Traded Fund | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| 1 month | +5.92% | +5.97% |
| 3 months | −2.60% | −2.55% |
| 6 months | +1.69% | +1.72% |
| YTD | +2.62% | +2.66% |
| 1 year | +2.02% | +2.08% |
| 3 years (CAGR) | +13.88% | +13.87% |
| 5 years (CAGR) | — | +14.66% |
| 10 years (CAGR) | — | — |
| Since launch | +14.70% | +18.99% |
Risk
| UTI Nifty Midcap 150 Exchange Traded Fund | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| Volatility | 18.3% | 18.3% |
| Downside volatility | 12.5% | 12.4% |
| Sharpe | 0.40 | 0.40 |
| Sortino | 0.59 | 0.59 |
| Calmar | 0.66 | 0.66 |
| Return / risk | 0.76 | 0.76 |
| Deepest fall | −20.98% | −38.35% |
| Days to recover | 262 | 228 |
| Below its high | −3.25% | −3.21% |
Against benchmark
| UTI Nifty Midcap 150 Exchange Traded Fund | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| Alpha | +0.01% | +0.00% |
| Beta | 1.00 | 1.00 |
| R² | 100.0% | 100.0% |
| Up capture | 100.1% | 100.0% |
| Down capture | 100.2% | 100.0% |
| Tracking error | 0.1% | 0.0% |
| Information ratio | 0.19 | — |
| Treynor | 0.06 | 0.06 |
Consistency
| UTI Nifty Midcap 150 Exchange Traded Fund | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| Best 1-year | +50.21% | +116.74% |
| Middle 1-year | +7.49% | +14.06% |
| Worst 1-year | −5.89% | −33.73% |
| 1-year periods with a loss | 12.4% | 11.6% |
| Middle 3-year | +13.87% | +24.17% |
| Positive months | 66.7% | 66.7% |
| Best day | +3.97% | +3.95% |
| Worst day | −7.11% | −7.10% |
| Worst 5% day | −2.00% | −2.00% |
| Positive days | 57.2% | 57.1% |
| NAVs a year | 248 | 248 |
SIP of ₹10,000 a month
| UTI Nifty Midcap 150 Exchange Traded Fund | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| 5-year XIRR | — | +14.79% |
| 5-year value | — | ₹8,75,434 |
| 3-year XIRR | +7.86% | +7.85% |
| 1-year XIRR | +6.12% | +6.18% |
Holdings overlap i
| UTI Nifty Midcap 150 Exchange Traded Fund | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| UTI Nifty Midcap 150 Exchange Traded Fund | — | 98% |
| Nippon India ETF Nifty Midcap 150 | 98% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | UTI Nifty Midcap 150 Exchange Traded Fund | Nippon India ETF Nifty Midcap 150 |
|---|---|---|
| Laurus Labs Limited | 2.39% | 2.41% |
| The Federal Bank Limited | 2.14% | 2.16% |
| Multi Commodity Exchange of India Limited | 2.08% | 2.09% |
| The Indian Hotels Company Limited | 1.82% | 1.83% |
| Coforge Limited | 1.82% | 1.83% |
| One 97 Communications Limited | 1.80% | 1.81% |
| Hero MotoCorp Limited | 1.71% | 1.72% |
| Persistent Systems Limited | 1.68% | 1.69% |
| Bharat Heavy Electricals Limited | 1.44% | 1.45% |
| IndusInd Bank Limited | 1.41% | 1.42% |
| AU Small Finance Bank Limited | 1.28% | 1.29% |
| Lenskart Solutions Limited | 1.27% | 1.28% |
| Ge Vernova T&D India Limited | 1.27% | 1.28% |
| Lupin Limited | 1.25% | 1.25% |
| Life Insurance Corporation Of India | 1.24% | 1.25% |
| Indus Towers Limited | 1.24% | 1.25% |
| FSN E-Commerce Ventures Limited | 1.22% | 1.23% |
| IDFC First Bank Limited | 1.22% | 1.23% |
| Bharat Forge Limited | 1.22% | 1.23% |
| Aurobindo Pharma Limited | 1.19% | 1.19% |
| Info Edge (India) Limited | 1.18% | 1.18% |
| Dixon Technologies (India) Limited | 1.17% | 1.18% |
| Marico Limited | 1.08% | 1.09% |
| Ashok Leyland Limited | 1.06% | 1.06% |
| Suzlon Energy Limited | 1.05% | 1.06% |
Sectors and company size
| UTI Nifty Midcap 150 Exchange Traded Fund | Nippon India ETF Nifty Midcap 150 | |
|---|---|---|
| Large companies | 5.8% | 5.9% |
| Mid companies | 90.6% | 90.7% |
| Small companies | 2.5% | 2.5% |
| Top 10 holdings | 18.3% | 18.4% |
| Largest sector | Pharmaceuticals & Biotechnology 10% | Pharmaceuticals & Biotechnology 10% |